Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3020% below fair value
$9.17+0.06 (+0.66%)
Close on Nov 13, 2026Market cap $349.27MP/E 24.1Yield –
Viemed Healthcare ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Viemed Healthcare's ebitda for the twelve months ending Sep 30, 2026 was $40.06M, up 15.3% year over year. For fiscal 2025 it was $51.56M, up 19.2% from the year before.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.56M | +19.2% |
| FY2024 | Dec 31, 2024 | $43.27M | +19.6% |
| FY2023 | Dec 31, 2023 | $36.19M | +51.5% |
| FY2022 | Dec 31, 2022 | $23.88M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.35M | +21.8% |
| Q2 FY2026 | Jun 30, 2026 | $4.85M | -11.0% |
| Q1 FY2026 | Mar 31, 2026 | $11.92M | +14.0% |
| Q4 FY2025 | Dec 31, 2025 | $15.94M | +24.4% |
| Q3 FY2025 | Sep 30, 2025 | $6.04M | +1.1% |
| Q2 FY2025 | Jun 30, 2025 | $5.45M | +36.4% |
| Q1 FY2025 | Mar 31, 2025 | $10.45M | +23.1% |
| Q4 FY2024 | Dec 31, 2024 | $12.82M | +14.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.98M | +29.2% |
| Q2 FY2024 | Jun 30, 2024 | $3.99M | +24.8% |
| Q1 FY2024 | Mar 31, 2024 | $8.49M | +26.8% |
| Q4 FY2023 | Dec 31, 2023 | $11.21M | – |
| Q3 FY2023 | Sep 30, 2023 | $4.63M | – |
| Q2 FY2023 | Jun 30, 2023 | $3.20M | – |
| Q1 FY2023 | Mar 31, 2023 | $6.70M | – |
See a number that looks wrong?